The Japan Patent Office has issued a Decision to Grant a Patent to BrainStorm Cell Therapeutics (NASDAQ:BCLI) entitled “Method of Qualifying Cells” protecting NurOwn. The patent covers cell populations that are therapeutic for the treatment of ALS and the method of qualifying the cells for therapeutic use.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.